Progress of antiplatelet therapy in diabetic patients.
- VernacularTitle:糖尿病患者抗血小板治疗新进展
- Author:
Wenying YANG
- Publication Type:Journal Article
- Keywords:
diabetes;
cardiovascular disease;
aspirin
- From:
Chinese Journal of Practical Internal Medicine
2001;0(03):-
- CountryChina
- Language:Chinese
-
Abstract:
Many studies have shown that aspirin can effectively reduce risks for atherothrombosis in diabetic patients.The most recent American Diabetes Association(ADA) guidelines and the China Guideline For Type 2 Diabetics recommended aspirin therapy in diabetic patients(with no contraindications) who are over the age of 40,and in those 30 to 40-year-old diabetic patients with any long existing CVD risk factors;the recommended dose is 100(75~162)mg/d.Aspirin is safe,and its cost-effective profile has been well-established also.
